Trial Details

COMPLETED
Basic Information
Clinical ID c1423
Identifier NCT01959165
Trial Title MEDI7183 Phase 2 Study in Japanese Ulcerative Colitis Patients
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Ulcerative Colitis
Interventions DRUG: MEDI7183 low dose|DRUG: MEDI7183 medium dose|DRUG: MEDI7183 high dose|DRUG: Matching Placebo
Participant Information
Sponsor AstraZeneca
City Chikushino-shi
Country/Region Japan
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2013-11-21
Primary Completion Date 2015-08-11
Completion Date 2018-04-10